Your browser doesn't support javascript.
loading
Idiopathic juvenile osteoporosis-a polygenic disorder?
Wade, Emma; Mulholland, Katie; Shaw, Ian; Cundy, Tim; Robertson, Stephen.
Afiliación
  • Wade E; Department of Women's & Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, 9016, New Zealand.
  • Mulholland K; Department of Women's & Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, 9016, New Zealand.
  • Shaw I; Department of Pediatrics, Southland Hospital, Invercargill, 9812, New Zealand.
  • Cundy T; Department of Medicine, Faculty of Medical & Health Sciences, University of Auckland, Auckland, 1023, New Zealand.
  • Robertson S; Department of Women's & Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, 9016, New Zealand.
JBMR Plus ; 8(9): ziae099, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39193113
ABSTRACT
Idiopathic juvenile osteoporosis (IJO) is a rare condition presenting with vertebral and metaphyseal fractures that affects otherwise healthy prepubertal children. Bone mineral density (BMD) measurements are very low. The primary problem appears to be deficient bone formation, with a failure to accrue bone normally during growth. The onset in childhood suggests IJO is a genetic disorder, and a number of reports indicate that some children carry heterozygous pathogenic variants in genes known to be associated with defective osteoblast function and low bone mass, most commonly LRP5 or PLS3. However, a positive family history is unusual in IJO, suggesting the genetic background can be complex. We describe a young man with classical IJO who was investigated with a bone fragility gene panel and whole genome sequencing. The proband was found to carry four variants in three different genes potentially affecting osteoblast function. From his mother he had inherited mutations in ALPL (p.Asn417Ser) and LRP5 (p.Arg1036Gln), and from his father mutations in LRP5 (p.Asp1551Alsfs*13) and activating transcription factor 4 (ATF4) (p.Leu306Ile). His sister had also inherited the LRP5 (p.Asp1551Alsfs*13) from her father, but not the ATF4 mutation. Their spinal BMD z-scores differed substantially (sister -1.6, father -3.2) pointing to the potential importance of the ATF4 mutation. Activating transcription factor 4 acts downstream from RUNX2 and osterix and plays an important role in osteoblast differentiation and function. This case, together with others recently published, supports the view that IJO can result from clustering of mutations in genes related to osteoblast development and function. Novel genes in these pathways may be involved. Our case also emphasizes the value of detailed study of other family members. After a bone biopsy had excluded a mineralization defect due to hypophosphatasia, the proband was treated with zoledronate infusions with good clinical effect.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: JBMR Plus Año: 2024 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: JBMR Plus Año: 2024 Tipo del documento: Article País de afiliación: Nueva Zelanda